The GSTZ1 gene helps the body break down tyrosine, a building block of protein, and also affects how some medicines are cleared. If this gene does not work properly, chemical byproducts can build up, and in rare inherited cases this may lead to metabolic symptoms, liver problems, or developmental delay. Variants in the GSTZ1 gene can also change how strongly a person responds to certain treatments.
What is a gene?
Genes are sections of DNA that hold instructions your cells use to make molecules or manage processes throughout the body. Some genes provide the directions for producing proteins, the parts of cells that do much of the work. Others mainly guide when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can also influence how you respond to food, stress, and medications. For a deeper look at this topic, more information is available in the LearnHub.
Overview
GSTZ1Gene function
What if the gene works
The GSTZ1 gene helps your body break down tyrosine, an amino acid from food, and process some chemicals in the liver. This helps limit buildup of byproducts.
Risk
What if the gene does not work
More disruptive variants in the GSTZ1 gene can cause a rare tyrosine breakdown condition. People may develop high tyrosine levels with liver problems and brain or developmental features, ranging from milder findings to early, more severe illness.
Treatment
What does that mean for your treatment
No GSTZ1-specific treatment or management approach is currently established in clinical guidelines for people with a pathogenic variant in the GSTZ1 gene. The GSTZ1 gene is being studied as a biomarker for how the body handles dichloroacetate, a drug used mainly in research and limited clinical settings.
Gene function
What if the gene works
Your liver uses the GSTZ1 gene during everyday chemical housekeeping. It helps with one step in breaking down tyrosine, a building block from protein, and it also processes a small set of medicines and other chemicals. This gives a clear picture of how the GSTZ1 gene helps break down tyrosine and handle selected compounds in the body.
In liver cells, the GSTZ1 gene carries out a key step in breaking down tyrosine, a protein building block from food. This lets the breakdown products move into later steps the body uses for energy and routine chemical balance.
The GSTZ1 gene also helps change a small group of chemicals, including some medicines, into forms the body can handle more easily. This supports the liver’s broader job of processing substances that enter the bloodstream.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the GSTZ1 gene may alter the enzyme’s shape, stability, or amount, so its activity is reduced or lost. In understanding how GSTZ1 gene variants affect enzyme activity, some changes only partly lower function, while more disruptive variants can leave the protein unstable or nearly inactive, which may lead to a larger buildup of pathway chemicals inside cells. When loss of function is greater, related features can appear earlier or be more marked.
How variants are linked to conditions
Rare disease-causing variants in both copies of the GSTZ1 gene cause GSTZ1 deficiency, a very uncommon inherited metabolic condition that often starts in infancy or childhood. When clinicians describe GSTZ1 gene variants linked to conditions, they mainly mean this diagnosis, which may involve developmental delay, movement or balance problems, seizures, unusual blood or urine test results, and liver involvement in some people.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are common across the general population. Most do not have a direct effect on health and instead reflect natural variation among people. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also contribute. In some situations, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the GSTZ1 gene itself. GSTZ1 is more often discussed for how the body handles certain medicines than as a gene that clearly changes disease risk on its own, so personal concerns are best reviewed with a doctor or genetic counselor.
Inheritance of GSTZ1 variants
For GSTZ1-related hawkinsinuria, the GSTZ1 inheritance pattern is autosomal dominant. This means a child needs one disease-causing variant in the GSTZ1 gene to inherit the condition. If a parent carries that variant, each pregnancy has a 50% chance of passing it on to a son or daughter. Because GSTZ1 is on chromosome 14, this inheritance pattern is the same for males and females.
What does my GSTZ1 result mean for my family?
For GSTZ1, family implications are mainly tied to a rare inherited condition passed down in a recessive pattern. This usually means parents may be healthy carriers, and brothers or sisters could also be carriers or, less often, have the condition. Close relatives may want to learn whether the same result runs in the family, especially if there is a history of liver, nerve, or developmental problems.
Genetic information
Genetic testing
How you find out about variants
GSTZ1 genetic testing looks for variants in the GSTZ1 gene using DNA from a blood sample, saliva, or a cheek swab. The lab reads the gene’s code and compares it with the usual sequence to see whether a known variant is present.
When should I consider getting a genetic test?
Genetic testing for the GSTZ1 gene may be considered if a baby or child has signs of a rare inherited problem breaking down tyrosine, such as ongoing high tyrosine levels, poor growth, acidosis, or liver concerns. It can also help when there is a known family history of a GSTZ1-related condition.
A genetic result is only one part of your health story
Genetic findings can be informative, yet how much they reveal varies with the condition and the kind of variant present. Over time, the way the body functions is also shaped by factors like age, lifestyle, environment, and medical history. For some conditions, particularly those influenced by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can provide a clear answer. In areas like medication response, these results can also help place personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down, moves, or responds to a drug, so the same treatment may work better for one person than for another. These differences are common and can influence how much benefit someone gets from a medicine or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect medication response. By looking at links between genes and drugs, it helps explain why the same treatment may work differently in different people. For many medicines, genes influence both how strongly a drug works and how the body handles it. This information can support more informed, individualized treatment decisions. More on this topic is available in the LearnHub.
Drugs influenced by the GSTZ1 gene
When should I seek medical advice?
There isn't yet a broadly confirmed role for this gene in guiding routine medicine choices, so general questions about side effects, new symptoms, or how a medicine is working are best discussed with your doctor. GSTZ1 has mainly been studied for how the body handles dichloroacetate, but this has not become standard medication guidance in everyday care.
History
The GSTZ1 gene entered the scientific literature in the 1990s, when researchers identified it as part of the glutathione transferase family, a group of genes involved in handling chemicals in the body. Soon after, scientists recognized that GSTZ1 was unusual because it also matched an enzyme already known from tyrosine breakdown, linking two lines of research that had been studied separately. From these first observations, research expanded steadily. Interest grew further when GSTZ1 was shown to help process dichloroacetate, a drug studied for rare metabolic conditions and other illnesses. That finding made the GSTZ1 gene important in early pharmacogenetics, the study of how genes can shape drug response. Over time, this work helped clarify why people may process the same medicine differently.